Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
David J. Kuter(Harvard University), Janet L. Nichol(Amgen (United States)), Francis J. Cuevas(Marshall University), Adrian C. Newland(Queen Mary University of London), Miguel Á. Sanz(Instituto de Investigación Sanitaria La Fe), Jeffrey S. Wasser(Community Cancer Center), Vinod Pullarkat(City of Hope), Roger M. Lyons(Hematology Oncology Associates), Solomon I. Hamburg(Tower Cancer Research Foundation), Ronald S. Go(Mayo Clinic), Troy H. Guthrie(Baptist Cancer Center), Lawrence Rice(Methodist Hospital), Martin R. Schipperus(Rijnland Ziekenhuis), Craig M. Kessler(Georgetown University), Robert L. Redner(UPMC Hillman Cancer Center), Louis M. Aledort(Icahn School of Medicine at Mount Sinai), Frank T. Slovick(Hematology Oncology Associates), James N. George(University of Oklahoma), Jean‐François Viallard(Université de Bordeaux), James B. Bussel(Cornell University), Howard A. Liebman(Keck Hospital of USC), Howard R. Terebelo(Michigan Cancer Research Consortium), Francis M. Senecal(Northwest Medical Specialties), Terry Gernsheimer(Bloodworks Northwest), François Lefrère(Hôpital Necker-Enfants Malades), J. Th. M. de Wolf(University Medical Center Groningen), Alan Lichtin(Cleveland Clinic), David H. Henry(Pennsylvania Hospital), Ding‐Ding Guo(Amgen (United States)), Michael D. Tarantino(Bleeding & Clotting Disorders Institute), Emmanuelle Bourgeois(Hôpital Claude Huriez), Carlos Grande(Research Institute Hospital 12 de Octubre)
Cited by 862
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k